05/19/2026 | Press release | Distributed by Public on 05/19/2026 14:02
|
Section
|
Page
|
|
Letter to Shareholders and Management's Discussion of Fund Performance
|
1
|
|
Summary of Certain Unaudited Portfolio Characteristics
|
3
|
|
Fees and Expenses
|
5
|
|
Statement of Assets and Liabilities
|
7
|
|
Schedule of Investments
|
8
|
|
Statement of Operations
|
11
|
|
Statements of Changes in Net Assets
|
12
|
|
Statement of Cash Flows
|
13
|
|
Financial Highlights
|
14
|
|
Notes to Financial Statements
|
16
|
|
Dividend Reinvestment Plan
|
35
|
|
Portfolio Proxy Voting Policies and Proxy Voting Record
|
36
|
|
Additional Information
|
37
|
|
Summary of Underlying Portfolio
|
|
|
Number of Unique Underlying Loan Obligors
|
1,423
|
|
Number of Underlying Loans
|
1,850
|
|
Aggregate Balance of Underlying Loans
|
$17.89 Billion
|
|
Average Individual Loan Obligor Exposure
|
0.07%
|
|
Currency: USD Exposure
|
100.00%
|
|
Aggregate Indirect Exposure to Senior Secured Loans
|
97.18%
|
|
Weighted Average Junior OC Cushion
|
4.18%
|
|
Weighted Average Market Price of Loan Collateral
|
94.32
|
|
Weighted Average Remaining CLO Reinvestment Period
|
3.28 years
|
|
CCIF's Last 12 Month Default Rate including Distressed Exchanges of
Underlying Loans
|
1.18%
|
|
Loan Market Default Rate including Distressed Exchanges
|
3.04%
|
|
Top 10 Underlying Obligors
|
|
|
Obligor
|
% Total
|
|
TransDigm
|
0.60%
|
|
Hologic
|
0.46%
|
|
TIBCO Software
|
0.44%
|
|
Citadel Securities LP
|
0.44%
|
|
Jane Street Group
|
0.44%
|
|
Acrisure
|
0.42%
|
|
Quikrete Companies
|
0.41%
|
|
Sedgwick Claims Management Service
|
0.40%
|
|
Ensemble RCM
|
0.40%
|
|
Belron FIN 2019
|
0.40%
|
|
Total
|
4.41%
|
|
Top 10 Industries of Underlying Obligors
|
|
|
Industry
|
% Total
|
|
Healthcare & Pharmaceuticals
|
12.13%
|
|
High Tech
|
12.07%
|
|
Banking, Finance, Insurance & Real Estate
|
10.25%
|
|
Services: Business
|
8.62%
|
|
Hotels, Gaming & Leisure
|
5.15%
|
|
Capital Equipment
|
4.81%
|
|
Beverage, Food & Tobacco
|
4.37%
|
|
Construction & Building
|
4.08%
|
|
Aerospace & Defense
|
3.81%
|
|
Energy: Oil & Gas
|
3.66%
|
|
Total
|
68.95%
|
|
SHAREHOLDER TRANSACTION FEES
|
||
|
Sales load
|
-%
|
(1)
|
|
Offering expenses borne by the Fund
|
-%
|
(2)
|
|
Dividend reinvestment plan expenses
|
-%
|
(3)
|
|
Total shareholder transaction fees
|
-%
|
(4)
|
|
ESTIMATED ANNUAL FUND EXPENSES
(as a percentage of net assets attributable to common shares)
|
||
|
Management Fee
|
3.13%
|
(5)
|
|
Incentive Fee payable under Investment Advisory Agreement (17.5%)
|
1.23%
|
(6)
|
|
Interest payments and fees on borrowed funds
|
8.73%
|
(7)
|
|
Other Expenses
|
3.03%
|
(8)
|
|
Total annual fund expenses
|
16.12%
|
|
Example
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
Expenses on a $1,000 investment, assuming a 5%
annual return
|
$165
|
$441
|
$657
|
$1,012
|
|
March 31, 2026
|
||
|
ASSETS
|
||
|
Investments, at fair value (cost $174,665,811)
|
$122,889,556
|
|
|
Cash and cash equivalents
|
2,812,913
|
|
|
Interest receivable
|
3,610,272
|
|
|
Deferred financing costs
|
560,107
|
|
|
Prepaid expenses
|
163,490
|
|
|
Total assets
|
$130,036,338
|
|
|
LIABILITIES
|
||
|
Preferred Shares (net of unamortized deferred issuance costs of $1,744,233) (Note 7)
|
$49,272,767
|
|
|
Secured credit facility
|
8,000,000
|
|
|
Incentive fee payable
|
253,737
|
|
|
Management fee payable
|
393,621
|
|
|
Professional fees payable
|
309,736
|
|
|
Interest payable
|
261,081
|
|
|
Administration and custodian fees payable
|
256,427
|
|
|
Other payables and accrued expenses
|
439,495
|
|
|
Total liabilities
|
$59,186,864
|
|
|
COMMITMENTS AND CONTINGENCIES (Note 8)
|
||
|
Net Assets
|
$70,849,474
|
|
|
COMPOSITION OF NET ASSETS
|
||
|
Paid-in capital
|
$151,629,695
|
|
|
Total distributable earnings (losses)
|
(80,780,221)
|
|
|
Total Net Assets
|
$70,849,474
|
|
|
Common shares outstanding (no par value)
|
21,198,622
|
|
|
Net asset value per share of common stock
|
$3.34
|
|
Issuer (1)(7)
|
Investment Description
|
Acquisition
Date (2)
|
Principal
Amount
|
Cost
|
Fair Value (3)
|
% of Net
Assets
|
|
CLO - Equity(4)(5)
|
||||||
|
522 Funding CLO 2021-7, Ltd.
|
Subordinated Notes (effective yield 0.00%,
4/23/2034)8
|
7/27/2023
|
$4,505,000
|
$266,073
|
$27,030
|
0.04%
|
|
AGL CLO 17, Ltd.
|
Subordinated Notes (effective yield 9.76%,
1/21/2035)
|
5/6/2024
|
2,750,000
|
1,802,209
|
805,166
|
1.15%
|
|
Aimco CLO 10, Ltd.
|
Subordinated Notes (effective yield 8.27%,
7/22/2032)
|
11/27/2023
|
11,071,800
|
5,860,213
|
4,484,055
|
6.33%
|
|
Aimco CLO 14, Ltd.
|
Subordinated Notes (effective yield 10.23%,
10/20/2038)
|
7/17/2023
|
6,200,000
|
4,543,138
|
3,581,394
|
5.05%
|
|
Allegro XVII, Ltd.
|
Subordinated Notes (effective yield 13.70%,
7/25/2038)
|
5/07/2025
|
1,875,000
|
1,488,932
|
1,134,987
|
1.60%
|
|
Apidos CLO XXV, Ltd.
|
Subordinated Notes (effective yield 0.00%,
1/20/2037)8
|
7/1/2025
|
6,000,000
|
1,769,368
|
1,496,784
|
2.11%
|
|
Apidos CLO XXXIII, Ltd.
|
Subordinated Notes (effective yield 9.87%,
10/24/2034)6
|
7/25/2024
|
22,780,000
|
12,053,371
|
9,770,868
|
13.79%
|
|
Apidos CLO XXXIX, Ltd.
|
Subordinated Notes (effective yield 11.18%,
10/21/2038)
|
5/2/2024
|
7,058,000
|
4,477,670
|
3,548,254
|
5.01%
|
|
Ares LIX CLO, Ltd.
|
Subordinated Notes (effective yield 18.85%,
4/25/2034)
|
12/7/2023
|
8,000,000
|
4,125,084
|
2,231,943
|
3.15%
|
|
Ares LV CLO, Ltd.
|
Subordinated Notes (effective yield 11.40%,
10/15/2037)
|
8/19/2025
|
7,500,000
|
5,055,380
|
3,330,010
|
4.70%
|
|
Ares LVI CLO, Ltd.
|
Subordinated Notes (effective yield 14.14%,
1/25/2038)
|
8/24/2023
|
4,751,000
|
2,726,273
|
2,076,736
|
2.93%
|
|
Ares LX CLO, Ltd.
|
Subordinated Notes (effective yield 21.35%,
7/18/2034)
|
11/29/2023
|
1,600,000
|
745,336
|
461,279
|
0.65%
|
|
Ares LXXIV CLO, Ltd.
|
Subordinated Notes (effective yield 11.22%,
10/15/2037)
|
7/23/2025
|
4,000,000
|
3,141,285
|
1,898,956
|
2.68%
|
|
Audax CLO 12, Ltd.
|
Subordinated Notes (effective yield 18.77%,
4/22/2037)
|
3/03/2025
|
1,330,000
|
1,215,547
|
1,123,208
|
1.59%
|
|
Ballyrock CLO 16, Ltd.
|
Subordinated Notes (effective yield 12.36%,
7/20/2034)
|
8/20/2024
|
5,867,000
|
3,206,398
|
2,308,931
|
3.26%
|
|
Ballyrock CLO 18, Ltd.
|
Subordinated Notes (effective yield 9.68%,
4/15/2038)
|
8/16/2023
|
3,260,000
|
1,844,252
|
1,063,243
|
1.50%
|
|
Barings CLO, Ltd. 2019-III
|
Subordinated Notes (effective yield 15.31%,
1/20/2036)6
|
12/13/2023
|
7,695,466
|
3,405,880
|
2,122,282
|
3.00%
|
|
Barings CLO, Ltd. 2021-I
|
Subordinated Notes (effective yield 0.00%,
4/25/2034)8
|
7/17/2023
|
3,400,000
|
1,459,569
|
760,407
|
1.07%
|
|
Barings CLO, Ltd. 2025-I
|
Subordinated Notes (effective yield 11.47%,
4/20/2038)
|
2/14/2025
|
6,000,000
|
4,867,473
|
3,781,959
|
5.34%
|
|
Barings CLO, Ltd. 2025-VIII
|
Subordinated Notes (effective yield 14.24%,
1/15/2039)
|
12/03/2025
|
3,600,000
|
2,859,120
|
2,758,281
|
3.89%
|
|
Benefit Street Partners CLO XXIII,
Ltd.
|
Subordinated Notes (effective yield 20.08%,
4/25/2034)
|
8/02/2023
|
10,000,000
|
5,995,262
|
5,182,323
|
7.31%
|
|
Benefit Street Partners CLO
XXXVIII, Ltd.
|
Subordinated Notes (effective yield 8.88%,
1/25/2038)
|
12/17/2024
|
5,000,000
|
4,577,254
|
3,361,870
|
4.75%
|
|
Birch Grove CLO 3, Ltd.
|
Subordinated Notes (effective yield 9.14%,
1/19/2038)
|
9/4/2024
|
8,602,500
|
6,774,666
|
4,376,618
|
6.18%
|
|
CIFC Funding 2020-II, Ltd.
|
Subordinated Notes (effective yield 11.49%,
10/20/2034)
|
2/11/2025
|
9,032,000
|
4,567,308
|
3,470,369
|
4.91%
|
|
Elmwood CLO 17, Ltd.
|
Subordinated Notes (effective yield 8.62%,
7/17/2037)
|
8/13/2025
|
17,500,000
|
11,177,036
|
9,262,543
|
13.07%
|
|
Elmwood CLO VII, Ltd.
|
Subordinated Notes (effective yield 5.36%,
1/17/2034)
|
7/17/2023
|
3,400,000
|
1,542,041
|
827,546
|
1.17%
|
|
Empower CLO 2022-1, Ltd.
|
Subordinated Notes (effective yield 9.46%,
10/20/2037)
|
9/27/2024
|
9,500,000
|
7,233,696
|
4,181,068
|
5.90%
|
|
Galaxy XXII CLO, Ltd.
|
Subordinated Notes (effective yield 6.31%,
4/16/2034)
|
12/15/2023
|
3,560,000
|
1,923,511
|
986,151
|
1.39%
|
|
MidOcean Credit CLO XI, Ltd.
|
Subordinated Notes (effective yield 14.23%,
1/18/2036)
|
1/12/2024
|
6,250,000
|
3,713,384
|
2,275,269
|
3.21%
|
|
MidOcean Credit CLO XIV, Ltd.
|
Subordinated Notes (effective yield 8.10%,
4/15/2037)6
|
2/15/2024
|
6,750,000
|
4,299,873
|
2,936,473
|
4.14%
|
|
Neuberger Berman Loan Advisers
CLO 41, Ltd.
|
Subordinated Notes (effective yield 12.45%,
4/15/2034)
|
11/1/2023
|
4,500,000
|
2,402,581
|
1,298,962
|
1.83%
|
|
Niagara Park CLO, Ltd.
|
Subordinated Notes (effective yield 15.25%,
1/17/2038)
|
12/1/2023
|
7,850,000
|
4,268,420
|
2,694,351
|
3.80%
|
|
Issuer (1)(7)
|
Investment Description
|
Acquisition
Date (2)
|
Principal
Amount
|
Cost
|
Fair Value (3)
|
% of Net
Assets
|
|
Niagara Park CLO, Ltd.
|
Subordinated Notes (effective yield 11.67%,
1/17/2038)
|
11/6/2024
|
$79,398
|
$77,177
|
$77,100
|
0.11%
|
|
Oaktree CLO 2019-3, Ltd.
|
Subordinated Notes (effective yield 11.96%,
1/20/2038)
|
6/12/2025
|
3,500,000
|
1,991,588
|
1,238,292
|
1.76%
|
|
OCP CLO 2015-9, Ltd.
|
Subordinated Notes (effective yield 11.29%,
1/15/2037)
|
12/6/2023
|
21,847,700
|
7,806,134
|
5,399,162
|
7.62%
|
|
OCP CLO 2017-13, Ltd.
|
Subordinated Notes (effective yield 7.18%,
11/26/2037)
|
5/13/2025
|
17,897,237
|
5,818,714
|
4,508,360
|
6.36%
|
|
OHA Credit Partners XIII, Ltd.
|
Subordinated Notes (effective yield 11.65%,
10/21/2034)
|
7/17/2023
|
2,950,000
|
1,668,496
|
1,143,912
|
1.61%
|
|
Riverbank Park CLO, Ltd.
|
Subordinated Notes (effective yield 12.81%,
1/25/2038)
|
11/4/2025
|
9,950,000
|
7,583,726
|
5,621,025
|
7.93%
|
|
RR 12, Ltd.
|
Subordinated Notes (effective yield 0.00%,
1/15/2036)8
|
7/31/2024
|
8,542,000
|
1,457,461
|
983,474
|
1.39%
|
|
RR 6, Ltd.
|
Subordinated Notes (effective yield 0.00%,
4/15/2036)8
|
4/25/2024
|
2,206,250
|
708,449
|
144,055
|
0.20%
|
|
Silver Point CLO 4, Ltd.
|
Subordinated Notes (effective yield 14.64%,
4/15/2037)
|
2/28/2025
|
7,140,000
|
4,480,506
|
1,843,769
|
2.60%
|
|
Voya CLO 2020-2, Ltd.
|
Subordinated Notes (effective yield 11.22%,
7/19/2034)
|
8/02/2023
|
13,597,500
|
9,740,815
|
7,235,149
|
10.21%
|
|
Voya CLO 2020-3, Ltd.
|
Subordinated Notes (effective yield 10.62%,
1/20/2038)
|
8/3/2023
|
5,798,000
|
3,710,656
|
2,673,436
|
3.77%
|
|
Total CLO Equity
|
$170,431,325
|
$120,487,050
|
170.06%
|
|||
|
CLO - Debt(4)
|
||||||
|
Apidos CLO XXXIII, Ltd.
|
12.22% (3M Term SOFR + 8.55%,
4/24/2038)
|
4/23/2025
|
$250,000
|
$230,607
|
$227,506
|
0.32%
|
|
Total CLO Debt
|
$230,607
|
$227,506
|
0.32%
|
|||
|
Real Estate(9)
|
||||||
|
Moores Crossing - Travis County, TX
|
7/14/2023
|
$4,000,000
|
$4,003,879
|
$2,175,000
|
3.07%
|
|
|
Total Real Estate
|
$4,003,879
|
$2,175,000
|
3.07%
|
|||
|
Total Investments
|
$174,665,811
|
$122,889,556
|
173.45%
|
|||
|
Cash Equivalents
|
||||||
|
City National Bank MMDA
|
Money Market Deposit Account
|
$2,037,879
|
$2,037,879
|
$2,037,879
|
2.88%
|
|
|
U.S. Bank MMDA
|
Money Market Deposit Account
|
775,034
|
775,034
|
775,034
|
1.09%
|
|
|
Total Cash Equivalents
|
$2,812,913
|
$2,812,913
|
3.97%
|
|||
|
Total Investments and Cash
Equivalents
|
$177,478,724
|
$125,702,469
|
177.42%
|
|
Six Months Ended
March 31, 2026
|
||
|
Investment Income
|
||
|
Interest income
|
$12,661,704
|
|
|
Total investment income
|
12,661,704
|
|
|
Expenses
|
||
|
Interest expense
|
5,539,868
|
|
|
Management fees
|
1,572,708
|
|
|
Incentive fees
|
253,737
|
|
|
Professional fees
|
659,687
|
|
|
Administration and custodian fees
|
331,722
|
|
|
Insurance expense
|
119,173
|
|
|
Printing expense
|
85,565
|
|
|
Transfer agent fees
|
89,255
|
|
|
Trustees' fees and expenses
|
62,329
|
|
|
Other expenses
|
58,757
|
|
|
Total expenses
|
8,772,801
|
|
|
Net Investment Income
|
3,888,903
|
|
|
Net Realized and Unrealized Gain (Loss)
|
||
|
Net realized gain (loss) on investments
|
(12,835,266)
|
|
|
Net change in unrealized appreciation (depreciation) on investments
|
(37,716,591)
|
|
|
Net Realized and Unrealized Gain (Loss)
|
(50,551,857)
|
|
|
Net Decrease in Net Assets Attributable to Common Shares from Operations
|
$(46,662,954)
|
|
|
Six Months Ended
March 31, 2026
|
Year Ended
September 30, 2025
|
|||
|
Net increase (decrease) in net assets from operations:
|
||||
|
Net investment income
|
$3,888,903
|
$15,208,865
|
||
|
Net realized gain (loss) on investment transactions
|
(12,835,266)
|
(17,706,825)
|
||
|
Net change in unrealized appreciation (depreciation) on investments
|
(37,716,591)
|
(3,504,909)
|
||
|
Net decrease in net assets resulting from operations
|
(46,662,954)
|
(6,002,869)
|
||
|
Distributions to shareholders from:
|
||||
|
Net investment income
|
(12,401,194)
|
(10,363,754)
|
||
|
Return of capital
|
-
|
(13,459,803)
|
||
|
Total distributions to shareholders
|
(12,401,194)
|
(23,823,557)
|
||
|
Capital share transactions
|
||||
|
Net increase (decrease) in net assets resulting from beneficial interest:
|
||||
|
Issuance of common shares
|
-
|
40,303,512
|
||
|
Reinvestment of dividends
|
-
|
1,823,533
|
||
|
Net increase in net assets from capital share transactions
|
-
|
42,127,045
|
||
|
Total increase (decrease) in net assets
|
(59,064,148)
|
12,300,619
|
||
|
Net assets at the beginning of the period
|
129,913,622
|
117,613,003
|
||
|
Net assets at the end of the period
|
$70,849,474
|
$129,913,622
|
||
|
Six Months Ended
March 31, 2026
|
||
|
Cash flows from operating activities
|
||
|
Net decrease in net assets resulting from operations
|
$(46,662,954)
|
|
|
Adjustments to reconcile net decrease in net assets from operations to net cash provided by operating activities:
|
||
|
Purchases of investments, net of change in payable for investments purchased
|
(14,513,070)
|
|
|
Proceeds from disposition of investments and reductions to investment cost value, net of change in receivable
for investments sold (1)
|
44,223,753
|
|
|
Net amortization on investments
|
(332)
|
|
|
Amortization of deferred issuance costs on preferred shares and credit facility
|
2,716,605
|
|
|
Net realized loss on investments
|
12,835,266
|
|
|
Net change in unrealized depreciation on investments
|
37,716,591
|
|
|
Changes in assets:
|
||
|
Decrease in interest receivable
|
2,582,483
|
|
|
Decrease in prepaid expenses and other assets
|
119,172
|
|
|
Changes in liabilities:
|
||
|
Decrease in incentive fee payable
|
(417,006)
|
|
|
Increase in management fee payable
|
87,989
|
|
|
Decrease in interest payable on preferred shares
|
(105,147)
|
|
|
Decrease in professional fees payable
|
(429,547)
|
|
|
Increase in administration and custodian fees payable
|
93,713
|
|
|
Increase in other payables and accrued expenses
|
217,195
|
|
|
Net cash provided by operating activities
|
38,464,711
|
|
|
Cash flows from financing activities
|
||
|
Borrowings on credit facility
|
18,500,000
|
|
|
Repayments on credit facility
|
(17,250,000)
|
|
|
Proceeds from the issuance of preferred shares
|
47,500,000
|
|
|
Deferred issuance costs for the issuance of preferred shares
|
(2,466,224)
|
|
|
Payments on preferred shares redeemed, net of redemptions payable
|
(72,000,000)
|
|
|
Dividends paid to shareholders
|
(12,401,194)
|
|
|
Net cash used in financing activities
|
(38,117,418)
|
|
|
Net increase in cash and cash equivalents
|
347,293
|
|
|
Cash and cash equivalents, beginning of period
|
2,465,620
|
|
|
Cash and cash equivalents, end of period
|
$2,812,913
|
|
Supplemental information:
|
||
|
Cash paid for interest on preferred shares
|
$2,770,675
|
|
Six Months
Ended March
31, 2026
|
Year Ended September 30,
|
|||||||||
|
2025
|
2024
|
2023(7)
|
2022
|
|||||||
|
Per Share Operating Data
|
||||||||||
|
Net asset value, beginning of period
|
$6.13
|
$7.64
|
$8.42
|
$10.39
|
$11.69
|
|||||
|
Income (loss) from investment operations:
|
||||||||||
|
Net investment income (1)
|
0.18
|
0.81
|
1.19
|
0.05
|
0.50
|
|||||
|
Net realized and unrealized gain (loss) (2)
|
(2.38)
|
(1.13)
|
(0.74)
|
(1.20)
|
(0.80)
|
|||||
|
Total from investment operations
|
(2.20)
|
(0.32)
|
0.45
|
(1.15)
|
(0.30)
|
|||||
|
Dividends to shareholders from:
|
||||||||||
|
Net investment income (3)
|
(0.59)
|
(0.55)
|
(0.03)
|
(0.43)
|
(0.73)
|
|||||
|
Net realized gains (3)
|
-
|
-
|
-
|
-
|
(0.18)
|
|||||
|
Return of capital (3)
|
-
|
(0.71)
|
(1.20)
|
(0.40)
|
(0.09)
|
|||||
|
Total dividends
|
(0.59)
|
(1.26)
|
(1.23)
|
(0.82)
|
-
|
(1.00)
|
||||
|
Effect of shares issued
|
$-
|
$0.07
|
$-
|
$-
|
$-
|
|||||
|
Net asset value, end of period
|
$3.34
|
$6.13
|
$7.64
|
$8.42
|
$10.39
|
|||||
|
Per share market value at beginning of period
|
$5.82
|
$8.23
|
$8.18
|
$8.92
|
$10.49
|
|||||
|
Per share market value at end of period
|
$3.21
|
$5.82
|
$8.23
|
$8.18
|
$8.92
|
|||||
|
Total Return based on Net Asset Value (4)
|
(38.29)%
|
(3.74)%
|
6.07%
|
(11.75)%
|
(2.77)%
|
|||||
|
Total Return based on Market Value (5)
|
(36.94)%
|
(15.09)%
|
17.21%
|
0.39%
|
(5.95)%
|
|||||
|
Ratios/Supplemental Data
|
||||||||||
|
Net assets, end of period (in thousands)
|
$70,849
|
$129,914
|
$117,613
|
$98,751
|
$107,829
|
|||||
|
Ratio of gross expenses to average net assets (6)
|
16.68%
|
13.85%
|
12.92%
|
7.42%
|
3.27%
|
|||||
|
Ratio of net expenses to average net assets (6)
|
16.68%
|
13.85%
|
12.92%
|
6.72%
|
3.09%
|
|||||
|
Ratio of net expenses before incentive fees to average net
assets (6)
|
16.20%
|
11.36%
|
9.72%
|
N/A
|
N/A
|
|||||
|
Ratio of net investment income to average net assets (6)
|
7.39%
|
11.72%
|
15.10%
|
0.56%
|
4.53%
|
|||||
|
Portfolio turnover rate
|
17.33%
|
28.91%
|
17.69%
|
100.91%
|
28.39%
|
|||||
|
Asset coverage of preferred shares and credit facility
|
220%
|
258%
|
285%
|
N/A
|
N/A
|
|||||
|
Loan Outstanding, End of Year/Period (in thousands) (8)
|
$8,000
|
$6,750
|
N/A
|
N/A
|
$7,455
|
|||||
|
Asset Coverage Ratio for Loan Outstanding (8)
|
1,623%
|
3,143%
|
N/A
|
N/A
|
1,546%
|
|||||
|
Asset Coverage, per $1,000 Principal Amount of Loan
Outstanding (8)
|
$16,233
|
$31,434
|
N/A
|
N/A
|
$15,463
|
|||||
|
Weighted Average Loans Outstanding (in thousands) (8)
|
$2,526
|
$7,542
|
N/A
|
$3,732
|
$8,051
|
|||||
|
Weighted Average Interest Rate on Loans Outstanding (8)
|
7.09%
|
7.45%
|
N/A
|
7.94%
|
4.50%
|
|||||
|
Senior Securities
|
||||||||
|
Class and Period Ended
|
Total Amount
Outstanding
Exclusive of
Treasury
Securities (1)
|
Asset
Coverage
Per Unit (2)
|
Involuntary
Liquidating
Preference
Per Unit (3)
|
Average
Market Value
Per Unit (4)
|
||||
|
Credit Facility
|
||||||||
|
March 31, 2026
|
$8,000,000
|
$16,233.31
|
$-
|
N/A
|
||||
|
September 30, 2025
|
$6,750,000
|
$31,434.17
|
$-
|
N/A
|
||||
|
8.75% Series A Term Preferred Shares
|
|
|||||||
|
September 30, 2025
|
$52,000,000
|
$64.48
|
$25.00
|
$25.74
|
||||
|
September 30, 2024
|
$52,000,000
|
$71.29
|
$25.00
|
$25.60
|
||||
|
7.125% Series B Convertible Preferred
Shares
|
|
|||||||
|
March 31, 2026
|
$3,517,000
|
$2,200.49
|
$1,000.00
|
N/A
|
||||
|
September 30, 2025
|
$3,517,000
|
$2,579.17
|
$1,000.00
|
N/A
|
||||
|
September 30, 2024
|
$11,517,000
|
$2,851.68
|
$1,000.00
|
N/A
|
||||
|
7.50% Series C Convertible Preferred
Shares
|
||||||||
|
September 30, 2025
|
$20,000,000
|
$2,579.17
|
$1,000.00
|
N/A
|
||||
|
7.375% Series D Term Preferred Shares
|
||||||||
|
March 31, 2026
|
$30,000,000
|
$55.01
|
$25.00
|
$25.17
|
||||
|
7.25% Series E Convertible Preferred
Shares
|
||||||||
|
March 31, 2026
|
$17,500,000
|
$2,200.49
|
$1,000.00
|
N/A
|
|
As of March 31, 2026
|
|||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||
|
Assets
|
|||||||
|
Cash Equivalents
|
$2,812,913
|
$-
|
$-
|
$2,812,913
|
|||
|
Collateralized Loan Obligations
|
-
|
-
|
120,714,556
|
120,714,556
|
|||
|
Real Estate
|
-
|
-
|
2,175,000
|
2,175,000
|
|||
|
Total Investments, at Fair Value
|
$2,812,913
|
$-
|
$122,889,556
|
$125,702,469
|
|||
|
For the Six Months Ended March 31, 2026
|
||||||
|
Collateralized
Loan
Obligations
|
Real Estate
|
Total
|
||||
|
Balance, beginning of period
|
$190,028,718
|
$2,175,000
|
$192,203,718
|
|||
|
Purchases of investments
|
14,513,070
|
-
|
14,513,070
|
|||
|
Proceeds from sales and paydowns of investments (1)
|
(33,275,707)
|
-
|
(33,275,707)
|
|||
|
Net realized gains (losses)
|
(12,835,266)
|
-
|
(12,835,266)
|
|||
|
Accretion of discount (premium)
|
332
|
-
|
332
|
|||
|
Net change in unrealized appreciation (depreciation)
|
(37,716,591)
|
-
|
(37,716,591)
|
|||
|
Balance, end of period
|
$120,714,556
|
$2,175,000
|
$122,889,556
|
|||
|
Net change in unrealized appreciation (depreciation) included in earnings related to
investments still held at the reporting date
|
$(42,245,835)
|
$-
|
$(42,245,835)
|
|||
|
As of March 31, 2026
|
|||||||||
|
Carrying Value
|
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
|||||
|
Credit Facility (1)
|
$8,000,000
|
$8,000,000
|
$-
|
$-
|
$8,000,000
|
||||
|
7.125% Series B Convertible Preferred Shares (2)
|
3,517,000
|
3,360,965
|
-
|
-
|
3,360,965
|
||||
|
7.375% Series D Term Preferred Shares (3)
|
29,016,726
|
30,096,000
|
30,096,000
|
-
|
-
|
||||
|
7.25% Series E Convertible Preferred Shares (2)
|
16,739,041
|
16,368,800
|
-
|
-
|
16,368,800
|
||||
|
Total
|
$57,272,767
|
$57,825,765
|
$30,096,000
|
$-
|
$27,729,765
|
||||
|
Fair Value as of
March 31, 2026
|
Valuation
Techniques
|
Significant
Unobservable
Inputs
|
Range
|
Weighted
Average
|
|||||||
|
Low
|
High
|
||||||||||
|
Collateralized Loan Obligations
|
$119,416,284
|
Consensus Pricing
|
Indicative Quotes
|
0.60%
|
99.5%
|
45.9%
|
|||||
|
$1,298,272
|
Discounted Cash Flow
|
Discount Rate
|
20.0%
|
20.0%
|
20.0%
|
||||||
|
Real Estate
|
2,175,000
|
Market Approach
|
Bid Price
|
54.4%
|
54.4%
|
54.4%
|
|||||
|
Total Level 3 Investments
|
$122,889,556
|
||||||||||
|
Total Facility
|
Borrowings
Outstanding
|
Amount
Available (1)
|
|||
|
Credit Facility
|
$30,000,000
|
$8,000,000
|
$22,000,000
|
|
Initial Issuance
Date
|
Redemption
Date
|
Dividend
Rate
|
Share
Amount
|
Price Per
share
|
Total Raise
|
|
|
Series A Term
Preferred Shares
|
10/24/2023
|
11/3/2025
|
8.75%
|
2,080,000
|
$25.00
|
$52,000,000
|
|
Initial Issuance
Date
|
Redemption
Date
|
Dividend
Rate
|
Share
Amount
|
Price Per
share
|
Total Raise
|
|
|
Series B Convertible
Preferred Shares
|
8/27/2024
|
8/27/2029
|
7.125%
|
11,517
|
$1,000.00
|
$11,517,000
|
|
As of March 31, 2026
|
|
|
Series B Liquidation Preference
|
$3,517,000
|
|
Less: Unamortized deferred issuance costs(1)
|
-
|
|
Carrying value
|
$3,517,000
|
|
Fair value
|
$3,360,965
|
|
Fair value price per share
|
$955.63
|
|
Initial Issuance
Date
|
Redemption
Date
|
Dividend
Rate
|
Share
Amount
|
Price Per
share
|
Total Raise
|
|
|
Series C Convertible
Preferred Shares
|
1/31/2025
|
3/30/2026
|
7.50%
|
20,000
|
$1,000.00
|
$20,000,000
|
|
Initial Issuance
Date
|
Redemption
Date
|
Dividend
Rate
|
Share
Amount
|
Price Per
share
|
Total Raise
|
|
|
Series D Term
Preferred Shares
|
10/30/2025
|
10/30/2028
|
7.375%
|
1,200,000
|
$25.00
|
$30,000,000
|
|
As of March 31, 2026
|
|
|
Series D Liquidation Preference
|
$30,000,000
|
|
Less: Unamortized deferred issuance costs
|
983,274
|
|
Carrying value
|
$29,016,726
|
|
Fair value (1)
|
$30,096,000
|
|
Fair value price per share (1)
|
$25.08
|
|
Initial Issuance
Date
|
Redemption
Date
|
Dividend
Rate
|
Share
Amount
|
Price Per
share
|
Total Raise
|
|
|
Series E Convertible
Preferred Shares
|
10/30/2025
|
10/30/2030
|
7.25%
|
17,500
|
$1,000.00
|
$17,500,000
|
|
As of March 31, 2026
|
|
|
Series E Liquidation Preference
|
$17,500,000
|
|
Less: Unamortized deferred issuance costs
|
760,959
|
|
Carrying value
|
$16,739,041
|
|
Fair value
|
$16,368,800
|
|
Fair value price per share
|
$935.36
|
|
Outstanding Principal
Balance as of
|
|
|
March 31, 2026
|
|
|
Borrowings
|
|
|
Credit Facility
|
$8,000,000
|
|
Preferred Shares
|
|
|
Series B Convertible Preferred Shares
|
3,517,000
|
|
Series D Term Preferred Shares
|
30,000,000
|
|
Series E Convertible Preferred Shares
|
17,500,000
|
|
Total
|
$59,017,000
|
|
Weighted average interest rate
|
7.27%
|
|
Six Months Ended March
31, 2026
|
|
|
Federal tax cost of securities
|
$154,527,132
|
|
Gross unrealized appreciation
|
20,138,679
|
|
Gross unrealized depreciation
|
(51,776,255)
|
|
Net unrealized appreciation (depreciation)
|
$(31,637,576)
|
|
Adviser
|
Carlyle Global Credit Investment Management L.L.C.
|
|
Transfer Agent
|
Equiniti Trust Company LLC, (formerly known as American Stock Transfer & Trust
Company)
|
|
Legal Counsel
|
Dechert LLP
|
|
Ticker Symbols
|
|
|
Common Shares
|
CCIF
|
|
Preferred Shares
|
CCID
|
|
(a)(1)
|
Not applicable for semi-annual reports.
|
|
(a)(2)
|
Not applicable for semi-annual reports.
|
|
(a)(3)
|
Certifications required by Section 302 of the Sarbanes-Oxley Act of 2002 (and Item 19(a)(3) of Form N-CSR)
are filed herewith.
|
|
(b)
|
Certifications required by Section 906 of the Sarbanes-Oxley Act of 2002 (and Item 19(b) of Form N-CSR) are
filed herewith.
|